CAT and Hepatic steatosis: DOP increased the levels of GLP-1, High-density lipoprotein cholesterol (HDL-C), alleviated hepatic oxidative damage and reduced hepatic steatosis by elevating the levels of superoxide dismutase (SOD), catalase (CAT), and glutathione (GSH), and by lowering the level of MDA.